Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2019-A01008-49 | Other Identifier | ID-RCB number, ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Expert center of Parkinson's Disease (CHU Lille) | UNKNOWN |
| College of teaching general practitioners (CEMG Lille) | UNKNOWN |
| Regional Health Agency (ARS) | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| consultation with Parkinsun | Experimental |
| |
| consultation as usual without Parkinsun | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Consulting with PARKINSUN as communication aid-tool | Other | Participating patients visit their general practitioner or neurologist with PARKINSUN at 1 months, 4 months, 7 months |
|
| Measure | Description | Time Frame |
|---|---|---|
| variation of the delta of G-MISS Questionnaire | at 7 months |
| Measure | Description | Time Frame |
|---|---|---|
| G-MISS-Questionnaire at the end of each consultation (1 month, 4 months and 7 months) | Patient's satisfaction will be assessed by the G-MISS-Questionnaire. The G-MISS questionnaire is a standardized and validated tool in French. This questionnaire is taken from the American MISS-21 questionnaire, already used in neurologists to measure the satisfaction of patients with PD, after consultation It is easy to use with an average filling time of 6 minutes. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| David Devos, MD,PhD | Contact | 03 20 44 54 49 | +33 | david.devos@chru-lille.fr |
| Name | Affiliation | Role |
|---|---|---|
| David Devos | University Hospital, Lille | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hopital Roger Salengro, CHU Lille | Recruiting | Lille | 59037 | France |
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D012017 | Referral and Consultation |
| ID | Term |
|---|---|
| D011364 | Professional Practice |
| D009934 | Organization and Administration |
| D006298 | Health Services Administration |
Not provided
Not provided
| UCB Pharma |
| INDUSTRY |
| Orkyn' | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
| Consulting without PARKINSUN as communication aid-tool | Other | Participating patients visit their general practitioner or neurologist without PARKINSUN at 1 months, 4 months, 7 months |
|
| at the end of each consultation (1 month and 7 months) |
| Global score of PARKINSUN | at the end of each consultation ((1 month and 7 months) |
| Individuals scores of PARKINSUN | at the end of each consultation ((1 month and 7 months) |
| MDS-UPDRS scores | at the end of each consultation ((1 month and 7 months) |
| PDQ-39 scores 6. Interpersonal Reactivity Index (IRI) | at the end of each consultation ((1 month and 7 months) |
| Likert Scale | at the end of each consultation (1 month and 7 months) |
| Interpersonal Reactivity Index (IRI) | at the end of each consultation (1 month and 7 months) |
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |